Streszczenie
2/2022
vol. 124
Opis przypadku
Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept
- Department of Ophthalmology, Hospital Dr J. Michnowski, Bialystok, Poland
KLINIKA OCZNA 2022; 124, 2: 114-119
Data publikacji online: 2022/06/14
Pełna treść artykułu
AMA
Sienicka P. Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept. Klinika Oczna / Acta Ophthalmologica Polonica. 2022;124(2):114-119. doi:10.5114/ko.2022.116832.
APA
Sienicka, P. (2022). Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept. Klinika Oczna / Acta Ophthalmologica Polonica, 124(2), 114-119. https://doi.org/10.5114/ko.2022.116832
Chicago
Sienicka, Paulina. 2022. "Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept". Klinika Oczna / Acta Ophthalmologica Polonica 124 (2): 114-119. doi:10.5114/ko.2022.116832.
Harvard
Sienicka, P. (2022). Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept. Klinika Oczna / Acta Ophthalmologica Polonica, 124(2), pp.114-119. https://doi.org/10.5114/ko.2022.116832
MLA
Sienicka, Paulina. "Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 124, no. 2, 2022, pp. 114-119. doi:10.5114/ko.2022.116832.
Vancouver
Sienicka P. Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept. Klinika Oczna / Acta Ophthalmologica Polonica. 2022;124(2):114-119. doi:10.5114/ko.2022.116832.
